Search

Search Constraints

You searched for: Author/Creator Fagan, Anne

Search Results

1. P4–059: Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. (1st July 2013)

2. O4–01–01: Association of genetic variants with cerebrospinal fluid protein levels of ACE, MMP3 and other proteins and risk for Alzheimer's disease. (1st July 2013)

3. O4–02–03: Using cerebrospinal fluid markers to identify stages of National Institute on Aging and Alzheimer's Association proposed criteria for preclinical Alzheimer's disease and its prognosis. (1st July 2013)

4. IC‐P‐078: Dissociating volume and intensity differences in familial Alzheimer's disease. (1st July 2013)

5. IC‐O1–02: Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene‐dependent?. (1st July 2013)

6. IC‐O2–01: How do we define amyloid positivity in an asymptomatic population? Comparison of CSF, quantitative PET and clinical PET examinations. (1st July 2013)

7. IC‐P‐184: Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease. (1st July 2013)

8. P1–271: Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease. (1st July 2013)

9. P1–206: Quantitative label‐free proteomics for discovery of biomarkers in cerebrospinal fluid: Assessment of technical and inter‐individual variation. (1st July 2013)